Drug
AGuIX
AGuIX is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
2
50%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Completed1
Recruiting1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
completed125%
recruiting125%
terminated125%
unknown125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_1
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
NCT04789486
unknownphase_2
Radiotherapy of Multiple Brain Metastases Using AGuIX®
NCT03818386
terminatedphase_2
Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases
NCT04094077
completedphase_1
Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles
NCT02820454
Clinical Trials (4)
Showing 4 of 4 trials
NCT04789486Phase 1
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
NCT03818386Phase 2
Radiotherapy of Multiple Brain Metastases Using AGuIX®
NCT04094077Phase 2
Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases
NCT02820454Phase 1
Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4